Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP4 | P15090 | 6/20 | 0.96 |
| ▸ | FABP3 | P05413 | 2/20 | 0.96 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.96 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.45 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | ENPP3 | O14638 | 2/20 | 0.37 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.37 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.36 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.36 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.36 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.36 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.36 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL86091 | 0.98 | FABP4 (1.00) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL28511172 | 0.96 | FABP4 (0.96) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL28654070 | 0.96 | FABP4 (0.96) | FABP4FABP3FABP5GABRA1GABRB2 | |
| Hydrochloric Acid SCHEMBL6374692 | 0.96 | FABP4 (0.96) | FABP4FABP3FABP5GABRA1GABRB2 | |
| Ammonia Solution, Strong SCHEMBL17985319 | 0.96 | FABP4 (0.96) | FABP4FABP3FABP5GABRA1GABRB2 | |
| Tetramethylammonium Ion SCHEMBL592343 | 0.92 | FABP4 (0.89) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL12162268 | 0.90 | FABP4 (0.85) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL14022220 | 0.89 | FABP4 (0.82) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL12982857 | 0.89 | FABP4 (0.82) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL2607717 | 0.87 | FABP4 (0.79) | FABP4FABP3FABP5GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117597099-A | Curable composition for dental use | 可乐丽则武齿科株式会社 | 2024-02-23 | — | — | CN | disclosed |
| CN-113677293-B | Curable composition for dental restoration | 可乐丽则武齿科株式会社 | 2023-10-10 | — | — | CN | disclosed |
| CN-116367806-A | Curable composition for dentistry having excellent color tone adaptability | 可乐丽则武齿科株式会社 | 2023-06-30 | — | — | CN | disclosed |
| CN-106413666-B | Dental cement | 可乐丽则武齿科株式会社 | 2020-07-28 | — | — | CN | disclosed |
| US-8962233-B2 | Actinic-ray—or radiation-sensitive resin composition and method of forming pattern using the composition | FUJIFILM CORPORATION (JP) | 2015-02-24 | — | — | US | disclosed |
| US-20110189609-A1 | ACTINIC-RAY- OR RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD OF FORMING PATTERN USING THE COMPOSITION | FUJIFILM CORPORATION (JP) | 2011-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110189609-A1 | ACTINIC-RAY- OR RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD OF FORMING PATTERN USING THE COMPOSITION | ARSA, RER1, TERB1 | FABP4 1145/4885FABP3 1762/4885FABP5 1688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.